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Summary
Objective: Recently we described a canine model of osteoarthritis (OA), the groove model with features of OA at 10 weeks after induction,
identical to those seen in the canine anterior cruciate ligament transection (ACLT) model. This new model depends on cartilage damage
accompanied by transient intensified loading of the affected joint. The present study evaluates this groove model at 20 and 40 weeks after
induction, to assess whether the osteoarthritic features progress in time.
Methods: Grooves were made in the femoral condyles of one knee without damaging the subchondral bone. After surgery the dogs were
forced to load the experimental joint 3 days per week (4 hours/day) for 20 weeks by fixing the contralateral control limb to the trunk. After
20 weeks and 40 weeks (the last 20 weeks normal loading) joints were analysed for biochemical and histological features of OA.
Results: All biochemical cartilage parameters were indicative of OA and all these parameters suggested a slow progression of degeneration
over time from 20 to 40 weeks after induction, statistically significant for synthesis and content of proteoglycans as well as Mankin grade.
Synovial inflammation, which was mild, diminished slightly in time.
Conclusion: The degenerative joint damage in the canine groove model is slowly progressive over time in the first year. The cartilage
degeneration is induced by a one-time trauma and is not primarily mediated by synovial inflammation, which gives this model unique
characteristics compared to presently available models for studying early osteoarthritic features in vivo. In the groove model the effect of
treatment of cartilage damage is not counteracted by permanent joint instability or hampered by inflammation. Therefore, the model might
be more sensitive to detect effects of therapy, aimed at cartilage protection and repair. © 2002 Published by Elsevier Science Ltd on behalf
of OsteoArthritis Research Society International
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Osteoarthritis (OA) is a degenerative joint disease, which is
characterized by damage of articular cartilage and
subchondral bone and is frequently accompanied by sec-
ondary synovitis1,2. The disease progresses slowly and
develops over many years3, and age has been identified as
the main risk factor1,4. Most often, OA is diagnosed at a
relatively late stage of the disease because early markers
are not available yet. This may in part be the reason why a
disease modifying treatment for OA is still not available.
Ideally, therapies to prevent progression should be applied
early in the course of OA, and for this reason studying early
changes in OA is important. Several animal models of OA
have been developed to study the biochemical and histo-
logical changes associated with cartilage degeneration in
early stages of OA in vivo5,6.282Most of the animal models of OA have a permanent
trigger for inducing degenerative joint damage (mostly joint
instability as a result of e.g. ligament transection or partial
meniscectomy). The most frequently used model is the
canine anterior cruciate ligament transection (ACLT)
model. In this model, surgically induced ACLT results in
joint instability (being one of the causes of OA in humans7)
which is followed by early osteoarthritic features. Over the
course of several years this model leads to full-blown OA,
which resembles human clinically diagnosable OA8. This
model has been shown to be very useful to evaluate
treatment for slowing down the progression of OA9–17.
Unfortunately, the permanent joint instability persists as a
trigger for OA, which will counteract possible beneficial
effects of therapy. Moreover, degenerative changes are
depending at least in part on the synovial inflammation18.
This characteristic may hamper the evaluation of treatment
strategies, which are primarily aimed at cartilage protection
and repair more than at restraining (secondary) inflamma-
tion. For this reason, a model of OA which is evoked by
cartilage trauma (being another possible cause of OA in
humans19) with minimal inflammation may have additional
value for the evaluation of therapy.
Therefore, we have recently developed the groove
model of OA in the dog20. In this canine model, damage to
the articular cartilage of the weight-bearing areas of the
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ANIMALS
Ten female Beagle dogs, mean age 3.2±0.8 years,
weighing 10–15 kg, were obtained from the animal labora-
tory of the Utrecht University, the Netherlands. They were
housed in groups of 3–4 dogs per pen, and were let out on
a patio in large groups for at least 2 h daily. They were fed
a standard diet and had water ad libitum. The ten dogs
were divided randomly into 2 groups (mean age of 3.5±1.6
and 2.9±0.4 years; NS). The study was approved by the
Utrecht University Medical Ethical Committee for animal
studies.ANESTHESIA, GENERAL SURGERY, AND POST-SURGICAL
TREATMENT
After induction with Nesdonal, the dogs were anes-
thetized with halothane in a mixture of oxygen and nitrous
oxide delivered endotracheally. Surgery was carried out
through a 2 to 2.5 cm medial incision close to the ligamen-
tum patellae in one knee. Care was taken to prevent
bleeding and soft tissue damage as much as possible. After
surgery, synovium, fasciae and skin were sutured. The
contralateral unoperated knee served as a control. The
animals received analgesics (Buprenorphine 0.01 mg/kg)
and antibiotics (Amoxicyclin 400 mg/kg) during the first 3
days after surgery. Starting 2 days after surgery, the dogs
were let out daily on the patio, again. At the end of the
experiment, the dogs were killed with an intravenous injec-
tion of Euthesate (Na-Pentobarbital). Both hind limbs were
amputated and synovium and cartilage were collected andprocessed within 2 h. Procedures were carried out under
laminar flow conditions.GROOVE MODEL
In all dogs (N=10), the cartilage of the lateral and medial
condyles was damaged with a Kirschner-wire (1.5-mm
diameter) that was bent 90° at 0.5 mm from the tip. This
way the depth of the grooves was restricted to 0.5 mm. In
utmost flexion, 10 longitudinal and diagonal grooves were
made on the weight-bearing parts of the femoral condyles
without damaging the subchondral bone20. The latter was
checked by histology at the end of the experiment. There
was no absolute visual control over the procedure, but
macroscopic evaluation after killing of the animals showed
similar patterns in all affected knees. To ascertain (intensi-
fied) mechanical loading of the affected knee, the dogs
were forced to load the experimental joint intermittently by
fixing the contralateral limb to the trunk for approximately
4 h per day, 3 days per week, for 20 weeks. Thus, the
control limb was not weight bearing for less than 10% of the
time. Depending on the group, the severity of OA was
evaluated at 20 weeks or 40 weeks after surgery. In the
latter group the last 20 weeks were without intensified
loading.SYNOVIAL TISSUE ANALYSIS
Three infrapatellar synovial tissue samples per joint
(experimental and control) were fixed in 4% phosphate-
buffered formalin (pH 7.0) and embedded in paraffin wax.
Deparaffined sections were stained with hematoxylin-
eosin. The histological sections were examined separately
in random order and independently by two observers
unaware of the source of the synovium. Each specimen
was analysed to determine the degree of inflam-
mation, using the slightly modified21 criteria described by
Goldenberg and Cohen22. In brief, the severity of synovitis
was graded from 0–10 by adding the scores for three
histological criteria, namely synovial lining cell hyperplasia
(0–2), villous hyperplasia (0–3), and cellular infiltration by
(perivascular) mononuclear and polymorphonuclear leuko-
cytes (0–5). For assessing the overall grade, the three
specimens from each knee were considered as a unit.CARTILAGE ANALYSIS
Cartilage samples for histological and biochemical
analysis were obtained from predetermined locations on
the weight-bearing areas of the femoral condyles and the
tibial plateau of both experimental and control knee joints.
The locations are identically paired with the same location
in the contralateral joint20. Cartilage was cut as thick as
possible, while excluding the underlying bone. Samples
were cut into square full-thickness pieces, kept in 200 l
culture medium (Dulbecco’s Modified Eagle’s Medium
(DMEM) supplemented with 0.085 mM ascorbic acid, 2 mM
glutamine, 100 IU/ml penicillin, 100 mg/ml streptomycin,
and 10% heat-inactivated Beagle serum), and weighed
(3–10 mg).
For histology, samples from the femoral condyles and
tibial plateau (N=4 each) from each knee were fixed in 4%
phosphate-buffered formalin containing 2% sucrose
(pH 7.0). Cartilage degeneration was evaluated in
safranin-O fast-green iron hematoxylin-stained sections byfemoral condyles in one knee, not damaging the sub-
chondral bone and not causing joint instability, is the trigger
for joint damage. To strengthen this trigger for development
of OA, loading of the affected joint is intensified temporarily
by fixing the contralateral control limb to the trunk of the
dog. Biochemical and histological evaluation showed
degenerative changes in the joint, which closely resemble
those in the ACLT model. At 10 weeks, collagen was
damaged and proteoglycan turnover was disturbed: an
ineffective enhanced synthesis combined with an
enhanced release resulted in a diminished proteoglycan
content. Matrix metalloproteinase activity measured in
synovial fluid was enhanced. Histologically, moderate car-
tilage destruction, characterized by loss of safranin-O stain-
ing, fibrillation of the articular surface and chondrocyte
clustering, was evident. These characteristics of OA were
also observed at the tibial plateau, although this cartilage
was not harmed during surgery. All changes were very
constant between animals. Most important, only mild signs
of inflammation were present, as demonstrated histologi-
cally. All these features make the groove model suitable for
studying OA in vivo in an early stage of disease. Moreover,
assuming cartilage repair upon treatment is possible; the
trigger, being the cartilage damage itself, could be removed
by treatment. Therefore, the model would be suitable for
long-term follow-up even after treatment has stopped.
However, in this reasoning we assume the degenerative
changes as found 10 weeks after induction to be progres-
sive, and not to repair spontaneously. Therefore, in the
present study, joint damage in the canine groove model of
OA was evaluated 20 and 40 weeks after surgery.
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criteria of Mankin (grade 0–11)24. Specimens were graded
in random order by an observer unaware of the source of
the cartilage. The average score of eight specimens, from
femoral condyle and tibial plateau, was used for statistical
evaluation.
For biochemical analysis, the cartilage samples were
cultured individually in 96-well culture plates (NUNCLON®,
Denmark) in 200 l culture medium (Dulbecco’s Modified
Eagle’s Medium (DMEM) supplemented with 0.085 mM
ascorbic acid, 2 mM glutamine, 100 IU/ml penicillin,
100 mg/ml streptomycin, and 10% heat-inactivated Beagle
serum). Cartilage explants were cultured according to
standard procedures as described previously25. For
femoral condyles and tibial plateau, cartilage proteoglycan
(PG) content, PG synthesis, PG retention, and PG release
as well as DNA content were determined and averaged
for 12 explants per parameter26. Collagen damage was
determined and averaged for eight explants.DNA CONTENT
The DNA content of the cartilage samples was deter-
mined as a measure of the cellularity of the cartilage. In
part of a papain digest (see below) of the ex vivo cartilage
samples DNA was stained with the fluorescent dye Hoechst
33258 as described earlier27. Calf thymus DNA (Sigma
D-4764) was used as a reference. The DNA content of the
cartilage samples is expressed as mg DNA normalized to
the wet weight of cartilage (mg/g).COLLAGEN DAMAGE
Degraded collagen was measured as described by Bank
et al.28. In short, after extraction of PGs, degraded collagen
molecules in the insoluble collagen network were selec-
tively digested with -chymotrypsin at 37°C. The super-
natant, containing the fragments derived from the digested
collagen molecules, was removed and hydrolysed, as was
the insoluble matrix left after -chymotrypsin digestion. The
hydroxyproline content of both pools was used to calculate
the percentage of degraded collagen present in the
samples.PROTEOGLYCAN SYNTHESIS
As a measure of proteoglycan (PG) synthesis, the rate of
sulfate incorporation was determined ex vivo25. After 1 h of
pre-culture, 148 kBq Na235SO4 (Dupont, NEX-041-H,
carrier-free) in 10 l DMEM was added to each sample.
After 4 h, the cartilage samples were washed with cold PBS
and digested with papain for 2 h at 65°C. Glycosaminogly-
cans (GAG) were precipitated by addition of cetylpyridium
chloride (CPC), and 35SO2−4 -labeled GAG were measured
by liquid scintillation analysis. The total sulfate incorpor-
ation rate of each cartilage sample was calculated using
the specific activity of the medium and was normalized to
the wet weight of the explants. Synthetic activity is
expressed as nmoles of sulfate incorporated per hour per
gram wet weight of the cartilage (nmol/h/g).PROTEOGLYCAN RETENTION AND PG-RELEASE
As a measure of retention of newly synthesized PGs in
the cartilage, the release of 35SO2−-labeled PGs in the4medium was determined. After labeling (see above) the
cartilage samples were rinsed three times for 45 min in
1.5 ml complete medium and then incubated in 200 l fresh
culture medium without sulfate label for 3 days. Thereafter
the samples were washed with cold PBS and GAG were
precipitated from the medium and were stained with Alcian
Blue dye solution to measure the total release of GAG from
the cartilage, as described previously25. The 35SO2−4 -
labeled GAG were measured by liquid scintillation analysis
and the release was normalized to the specific activity of
the medium and the wet weight of the explants and
expressed as nmol/mg per 3 days. This release of newly
formed PGs is normalized to the total amount of newly
synthesized PGs and expressed as percentage release of
newly formed PGs in three days (% new PG release).
For the total release of PGs, blue staining was quantified
photometrically with chondroitin sulfate (Sigma C4384) as
a reference. The total amount of GAG released is
expressed as a percentage of the original tissue content
(see below; % total GAG release).PROTEOGLYCAN CONTENT
As a measure of PG content of the cartilage samples the
amount of GAG was determined as described previously25.
The GAG in the papain digest of cartilage samples were
precipitated and stained with Alcian Blue as described
above. The GAG content in mg was normalized to the wet
weight of the cartilage explants (mg/g).CALCULATIONS AND STATISTICS
For each animal, values of femoral and tibial cartilage
were taken together. Mean values±SEM (N=5 knees) of
control knees and experimental knees, respectively, are
presented. The paired student’s t-test was used to compare
data of the experimental and contralateral control joints in
the different groups, and the unpaired t-test was used to
analyse differences between the two groups. ANOVA was
used to compare data of control joints after 20 weeks, after
40 weeks, and from animals in which the control joints had
not been fixed to the trunk (with respect to the latter, data
not shown). P values less than 0.05 were considered
statistically significant.ResultsSYNOVIAL INFLAMMATION
Macroscopic evaluation of the synovial tissue showed no
signs of inflammation. Light microscopic examination of
synovial tissue showed very mild signs of inflammation in
the experimental joints compared to the contralateral con-
trol joints at twenty weeks (Fig. 1; P≤0.04). At 40 weeks
synovial inflammation was less severe (2 on a scale of 10),
but not statistically significantly different from inflammation
after 20 weeks.CARTILAGE DAMAGE
Macroscopic changes were comparable to those seen
10 weeks post-surgery20. The grooves made in the weight-
bearing cartilage of the femoral condyles could be seen
macroscopically in the experimental joints 20 weeks and 40
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Fig. 1. Synovial inflammation. Histology of the synovium, depicted
as modified Goldenberg and Cohen score (maximum score=10).
Mean values (N=5) ±S.E.M. are presented for control (h) and
experimental (") synovium of different groups with different follow-
up: 20 weeks=20-week follow-up with intensified loading, 20+20
weeks=40-week follow-up with the first 20 weeks intensified load-
ing. * Statistically significant (P<0.05) increase of synovial inflam-
mation of the experimental joints compared to contralateral control
joints are indicated.Fig. 2. Macroscopic view of the articular cartilage surface. Femoral condyles (lower panel) and tibial plateau (upper panel) of the control knee
(left panel) and experimental knee (right panel) at 40 weeks of follow-up are shown. Grooves and surrounding damage are clearly visible in
the experimental knees whereas the contralateral control knees show smooth, white healthy cartilage.weeks after surgery, and showed similar patterns for all
affected knees (Fig. 2). The surface of the cartilage around
the grooves, i.e. over the entire weight-bearing surface,
was slightly fibrillated. Although not surgically damaged,
the tibial plateau of the experimental joints showed similar
fibrillation at weight-bearing areas, but no grooves. Control
knee joints were normal, with smooth white cartilage.
Mechanical chondral damage combined with temporary
intensified loading of the affected joint resulted in mild
osteoarthritic features. Collagen is important for the tensile
strength of cartilage, and collagen damage is suggested to
be one of the first features in cartilage degeneration.
Twenty weeks after surgery collagen damage was
increased in the experimental joint compared to the control
joint (7.9±1.0% denatured collagen, 15% increased
compared to the contralateral control joint, P≤0.014; see
Table I). The increase in collagen damage in the exper-
imental joint was slightly more severe after 40 weeks
(8.4±0.3% denatured collagen, 26% increased compared
to the control joint, P≤0.004; see Table I).
Unsurprisingly, as a result of the damaged collagen
network there was an increased release of glycosaminogly-
cans. After 20 weeks, the percentage GAG release (nor-
malized to the GAG content) was increased to 77%
compared with the control joint [P≤0.0001; Fig. 3(a)]. After
40 weeks post-surgery, the change in GAG-release in the
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Changes in the experimental knee as a percentage of the contra-
lateral control knee (mean of femoral condyle and tibial plateau)
20 weeks P≤* 20+20
weeks
Synovial inflammation
Goldenberg and Cohen score† +1.6 NS +1.2
Chondrocyte proteoglycan turnover
% release of total PG +77 NS +78
PG-synthesis +102 0.01 +38
% release of new PG +65 NS +39
Cartilage matrix integrity
Collagen damage +15 NS +26
PG-content −7 0.05 −20
Mankin score† +1.5 0.01 +3.0
*P-values for comparison of the 20-weeks and 40-weeks
follow-up of the groove model.
†Absolute changes between experimental and control knees
were calculated.0
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Fig. 3. Changes in cartilage metabolism. Mean values (N=5)
±S.E.M. are presented for control (h) and experimental (") articular
cartilage (femur+tibia) of different groups with a different follow-up:
20 weeks=20-week follow-up with intensified loading, 20+20
weeks=40-week follow-up with the first 20 weeks intensified load-
ing. (a) total release of PGs in 3 days normalized to the GAG
content of the explants (% GAG release); (b) sulfate incorporation
rate as a measure of proteoglycan (PG) synthesis rate (nmol
SO2−4 /hour/gram wet weight of cartilage); (c) release of new PGs(release of newly formed PGs in 3 days normalized to the total
amount of newly formed PGs) as a measure for retention (% new
PG release). * Statistically significant increases of the parameters
for experimental joints compared to contralateral control joints are
depicted.experimental joint was similarly enhanced [plus 78%,
P≤0.001; Fig. 3(a)].
Proteoglycans are important for resilience of the carti-
lage. Chondrocytes attempt to repair the damaged car-
tilage matrix by increasing proteoglycan synthesis. At
20 weeks post-surgery, PG synthesis was increased in
the experimental joint compared to the contralateral
control joint [plus 102%, P≤0.002; Fig. 3(b)]. At 40 weeks
post-surgery, the repair activity was reduced, since the
increase in PG-synthesis was significantly lower [plus
38%, P<0.001; Fig. 3(b)] when compared with that in the
experimental joint after 20 weeks (P≤0.004).
The repair activity was not effective, since the release of
the newly formed PGs was increased in the experimental
joint compared to the control joint at 20 and 40 weeks
post-surgery [plus 65% and 39%, P≤0.0001 and P≤0.05,
respectively, Fig. 3(c)]. No statistically significant difference
was found between these two groups.
Increased PG-synthesis in the experimental joint was not
caused by an increased cellularity. After 20 and 40 weeks,
the cellularity of the cartilage, as determined by its DNA
content, was slightly decreased in the experimental
joints compared with the control joints (0.16±0.01 vs.
0.18±0.01 mg DNA per gram wet weight of cartilage,
P<0.02 after 20 weeks and 0.15±0.01 vs. 0.17±0.01 mg/g,
P≤0.03 after 40 weeks; data not shown), which was prob-
ably due to swelling of the cartilage as a result of the
damaged collagen network.
As a result of the increased percentage release of total
proteoglycans and of newly formed proteoglycans, the
PG-content of the cartilage matrix decreased in the exper-
imental joint compared to the control joint. Twenty weeks
after surgery PG-content was decreased by 7% (P≤0.04),
while 40 weeks after surgery PG-content was decreased by
20% (P≤0.009). The decrease in PG-content was statisti-
cally significantly larger at 40 weeks than at 20 weeks
post-surgery [Fig. 4(a); P≤0.047].
These biochemical osteoarthritic changes were consist-
ent with structural cartilage damage shown by histology.
Light microscopic evaluation of safranin-O stained cartilage
sections showed chondrocyte clusters around the cartilage
lesions and moderate loss of matrix PGs (representative
micrographs shown in Fig. 5). None of the grooves was
found to have penetrated the subchondral bone. The aver-
age modified Mankin score of cartilage degeneration of
Osteoarthritis and Cartilage Vol. 10, No. 4 287femoral and tibial cartilage in the experimental knee was
statistically significantly increased after 20 and 40 weeks
(Fig. 4; P≤0.002 and P≤0.0001, respectively). The histo-
logical damage was progressive in time, resulting in more
severe cartilage damage after 40 weeks (P≤0.01).THE CONTRALATERAL JOINT AS A CONTROL
The temporary unloading (less than 5% of time) of the
control joint could affect the parameters of these control
joints. Therefore, the control joints at 20 weeks and
40 weeks (the last 20 weeks normal loading) were com-
pared and both groups were compared with those of control
joints never fixed to the trunk of the dogs (the latter in
retrospect). None of the comparisons revealed statistically
significant differences (data not shown). This demonstratesthat the changes found in the experimental joints were not
dependent on changes in the contralateral control joints
and, therefore, were related to the degenerative process of
joint damage induced in the experimental joint.
As summarized in Table I, most changes related to
chondrocyte function and cartilage matrix integrity impaired
during the follow-up from 20 to 40 weeks, statistically
significantly for proteoglycan synthesis, proteoglycan con-
tent and histological grading. This slow progression in
cartilage damage was observed without an increase in
synovial inflammation (as judged by histology) over time.0
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Fig. 4. Structural cartilage damage. Changes in structural parameters of articular cartilage in the groove model, 20 weeks and 40 weeks after
surgery. Mean values (N=5) ±S.E.M. are presented for control (h) and experimental (") articular cartilage (femur+tibia) of different groups
with different follow-up: 20 weeks=20-week follow-up with intensified loading, 20+20 weeks=40-week follow-up with the first 20 weeks
intensified loading. (a) PG content depicted as GAG content (mg GAG per gram wet weight of cartilage); (b) cartilage histology, depicted as
modified Mankin score (maximum score=11). * Statistically significant increases of the parameters for experimental joints compared to
contralateral control joints are depicted.Fig. 5. Representative light micrographs of condylar cartilage (Safranin-O stained) obtained from a control joint (C: modified Mankin grade
0), an experimental joint 20 weeks after surgery (E: modified Mankin grade 3) and an experimental joint 40 weeks after surgery (E: modified
Mankin grade 5).Discussion
In the canine groove model, chondral damage applied to
condylar weight-bearing cartilage followed by transient
288 A. C. A. Marijnissen et al.: Steady progression of OA in the groove modelintensified loading of the affected joint, is shown to result
in slowly progressive osteoarthritic features. There are
several animal models available to study osteoarthritis,
each with its own characteristics. The presently described
model is unique in that it combines some of these charac-
teristics, making it possible to focus on cartilage repair,
being one of the primary causes of osteoarthritis, when
evaluating treatment.
Osteoarthritic features in the groove model are caused
by a one time trauma as has been shown for several other
strategies such as transarticular loading in the dog29. If
healing of cartilage damage is possible, a model using a
one-time trauma for the induction of osteoarthritic features
is suitable to investigate possible cure of the damage. The
chronicity of the cartilage degeneration in these models is
thought to be intrinsic to the damage itself. In the present
model chondral damage of the weight-bearing areas
appears sufficient in this respect. This approach is different
from several other models such as those using permanent
changes in alignment as a result of e.g. meniscectomy30,
permanent joint instability as a result of ligament
damage31,32, or primarily induced chondrocyte death as in
biochemically induced models of OA33. In these models,
the initiating trigger causing degenerative changes remains
present and contributes to the chronicity of the disorder.
Such permanent triggers have the disadvantage that they
counteract possible beneficial effects of therapy.
In our model, the chondral trauma is accompanied by
transient intensified loading of the affected joint. Trauma19
as well as increased loading3 are predisposing to human
OA. It is reported that neurectomy accelerates the osteo-
arthritic features after ligament transection in dogs, which is
expectedly dependent on intensified loading34. Appar-
ently, both triggers together strengthen the osteoarthritic
features. The intensified loading in the initiation phase has
been applied to ascertain significant weight bearing of the
joint, this also in view of the findings of Convery et al. who
showed that chondral defects in non-weight-bearing areas
repaired completely in contrast to defects in the weight-
bearing areas35. In our model, 20 weeks intensified loading
appears to be sufficient for a progressive degeneration of
cartilage.
The use of a large animal that still guarantees easy
handling has the advantage that characteristics of articular
cartilage, such as the relatively small number of chondro-
cytes in an abundant amount of extracellular matrix, mimic
human articular cartilage. The characteristics of specialized
chondrocytes in the different layers from superficial to
calcified zone6 can be distinguished in dog cartilage, in
contrast with joint cartilage of the smaller animal species.
Moreover, the amount of cartilage that can be obtained
from the weight-bearing areas is sufficient to perform
several biochemical and histological assays (i.e. multiple
samples per joint) with good reliability of the outcome
parameters per animal. In addition, using the Beagle
groove model allows good comparison with the Beagle
ACLT model20, which is the most frequently used model
of OA.
Finally, and most important, in the presently described
model synovial inflammation is very mild and does not
increase with time. This has an advantage when treatment
strategies are aimed more at chondroprotection and carti-
lage repair than at restraining inflammation. In models in
which cartilage damage is for a significant part depending
on the synovial inflammation18, evaluation of cartilage-
directed treatment strategies might be hampered by the
inflammatory activity.In summary, we demonstrate that in the canine groove
model the degenerative changes in cartilage matrix
integrity are slowly progressive over time in the first year
after induction, while synovial inflammation decreased. The
slowly progressive phase in the first year after the initial
induction phase is expected to proceed to full-blown osteo-
arthritic changes in several years which has been demon-
strated to occur within 5 years in the ACLT model8. Such a
slow progression would mimic human OA, which in general
is considered to be a very slow process in which progres-
sion to clinically diagnosable disease takes years3. In the
groove model, the effect of treatment aimed at cartilage
protection or repair is not counteracted by permanent joint
instability or hampered by inflammation. Therefore, the
model might be a valuable contribution to the search for
treatment strategies that result in repair of cartilage in OA.Acknowledgments
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